Skip to main navigation Skip to search Skip to main content

A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation-

Project: Research

Project Details

StatusFinished
Effective start/end date03/1/15 → 04/30/20

Funding

  • Novartis Pharmaceuticals Corporation: $88,020.00